“second-genome” Archives

in
Entry Author Date Location
Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal 04/08/20 San Francisco
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
With Yale Tech and $12M, Artizan Aims for Root Cause of Gut Disease 06/10/19 Boston
Gates Foundation, Bristol-Myers Join $27M Funding for Vedanta Bio 12/24/18 Boston
Microbiome Startup uBiome Expands into Drug Research with $83M 09/21/18 San Francisco
Grab Your Ticket for What’s Hot in Bay Area Biotech on Dec. 6 11/30/17 San Francisco
Evelo Bio Raises $50M Round to Bring Microbiome Drugs Into Trials 07/11/17 Boston
FDA Turmoil, Biology Mystery On List Of Hurdles For Microbiome Drugs 02/14/17 New York
Digitalis Launches $100M Health Fund, With Emphasis On Data 01/04/17 New York
In a Microbiome Setback, Seres Drug Fails in Phase 2, Shares Crushed 07/29/16 Boston
Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News 07/15/16 National
Second Genome Replaces DiLaura as CEO, Brings Series B to $51M 07/13/16 San Francisco
Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies 06/06/16 Boston
West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More 04/22/16 San Francisco
Probing Gut Microbiome, Second Genome Nabs $43M To Push Colitis Drug 04/20/16 San Francisco
Second Genome Lands $42,600,000 Series B Financing Round 04/20/16 San Francisco
With Startup, Bio Pioneer Tom Maniatis Looks to Spark NY Scene Again 12/10/15 New York
New Speakers Join Gene-Edit, Microbiome, Big Data “Disruptors” 12/10 12/02/15 San Francisco
What Three Biotechs Could Tell Us About The Pfizer-Allergan Merger 12/01/15 National
Agenda Posted: Xconomy’s Bay Area Life Science Disruptors On Dec. 10 11/19/15 San Francisco
Join Xconomy Dec. 10 To Hear From Bay Area Life Science Disruptors 11/12/15 San Francisco
Xconomy Forum: The Bay Area’s Life Science Disruptors 10/08/15 National
Protagonist Nabs $40M, Eyes 1st Trial Of Oral Peptide In Gut Disease 07/16/15 San Francisco
For Biotech Cowboys, It’s No Ride Into The Sunset 07/08/15 National
West Coast Biotech Roundup: Juno, Nektar, Kite, Glooko & More 03/19/15 Seattle
Ginkgo Bioworks Grabs $9M Series A For Building Organisms 03/18/15 Boston
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
West Coast Biotech Roundup: Tobira, Novartis, NantCell, & More 01/15/15 San Francisco
With Vedanta Deal, J&J Marks Big-Pharma Milestone in the Microbiome 01/13/15 Boston
Second Genome Has Begun First Drug Trial Based on Microbiome Secrets 01/12/15 San Francisco
Page 1 of 2 next page »